The Federal Medical-Biological Agency (FMBA) of Russia has announced the successful completion of preclinical trials for its cancer vaccine, demonstrating both safety and high efficacy. The vaccine, initially developed to combat colorectal cancer, showed significant reductions in tumor size and improved survival rates during clinical trials. FMBA head Veronika Skvortsova made the announcement at the Eastern Economic Forum (EEF). Further research is underway to develop vaccines for glioblastoma and melanoma. The 10th Eastern Economic Forum was held in Vladivostok from September 3-6 under the theme “The Far East: Cooperation for Peace and Prosperity.”
